These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 28104444

  • 1. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A, Hashemy SI, Aghaei M, Panjehpour M.
    Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.
    Ghasemi A, Saeidi J, Mohtashami M, Hashemy SI.
    Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
    Chambers SK, Wang Y, Gertz RE, Kacinski BM.
    Cancer Res; 1995 Apr 01; 55(7):1578-85. PubMed ID: 7882368
    [Abstract] [Full Text] [Related]

  • 11. A novel uPAg-KPI fusion protein inhibits the growth and invasion of human ovarian cancer cells in vitro.
    Zhao LP, Xu TM, Kan MJ, Xiao YC, Cui MH.
    Int J Mol Med; 2016 May 01; 37(5):1310-6. PubMed ID: 27035617
    [Abstract] [Full Text] [Related]

  • 12. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
    So J, Wang FQ, Navari J, Schreher J, Fishman DA.
    Gynecol Oncol; 2005 Jun 01; 97(3):870-8. PubMed ID: 15919106
    [Abstract] [Full Text] [Related]

  • 13. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
    Li H, Ye X, Mahanivong C, Bian D, Chun J, Huang S.
    J Biol Chem; 2005 Mar 18; 280(11):10564-71. PubMed ID: 15653692
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells.
    Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Terao T.
    J Biol Chem; 2004 Mar 05; 279(10):8567-76. PubMed ID: 14676209
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
    Mahanivong C, Chen HM, Yee SW, Pan ZK, Dong Z, Huang S.
    Oncogene; 2008 Feb 21; 27(9):1273-80. PubMed ID: 17724468
    [Abstract] [Full Text] [Related]

  • 16. GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.
    Guo F, Zhou Z, Dou Y, Tang J, Gao C, Huan J.
    Cytokine; 2012 Mar 21; 57(3):417-28. PubMed ID: 22226621
    [Abstract] [Full Text] [Related]

  • 17. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
    Zeng Y, Xie H, Qiao Y, Wang J, Zhu X, He G, Li Y, Ren X, Wang F, Liang L, Ding Y.
    Cancer Sci; 2015 Oct 21; 106(10):1385-93. PubMed ID: 26258642
    [Abstract] [Full Text] [Related]

  • 18. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
    Chen Z, Liu S, Xia Y, Wu K.
    Med Sci Monit; 2016 Dec 01; 22():4679-4691. PubMed ID: 27904131
    [Abstract] [Full Text] [Related]

  • 19. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J, Gao P, Xu Y, Li Z.
    Mol Med Rep; 2016 Sep 01; 14(3):2534-40. PubMed ID: 27432222
    [Abstract] [Full Text] [Related]

  • 20. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G, Fibbi B, Amuchastegui S, Corsiero E, Laverny G, Silvestrini E, Chavalmane A, Morelli A, Sarchielli E, Vannelli GB, Gacci M, Colli E, Maggi M, Adorini L.
    Prostate; 2009 Apr 01; 69(5):480-93. PubMed ID: 19107880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.